Cms Clinical Research Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-12-2024
- Paid Up Capital ₹ 0.10 M
as on 22-12-2024
- Company Age 10 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue 47.94%
(FY 2022)
- Profit 431.06%
(FY 2022)
- Ebitda 644.23%
(FY 2022)
- Net Worth 408.95%
(FY 2022)
- Total Assets 133.58%
(FY 2022)
About Cms Clinical Research
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anshula Gautam and Nidhi Singh serve as directors at the Company.
- CIN/LLPIN
U73100TG2014PTC096599
- Company No.
096599
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Nov 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Cms Clinical Research?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nidhi Singh  | Director | 02-Jul-2018 | Current |
| Anshula Gautam | Director | 28-Nov-2014 | Current |
Financial Performance of Cms Clinical Research.
Cms Clinical Research Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 47.94% increase. The company also saw a substantial improvement in profitability, with a 431.06% increase in profit. The company's net worth Soared by an impressive increase of 408.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Cms Clinical Research?
In 2021, Cms Clinical Research had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Clinical Research Network India Private LimitedActive 9 years 26 days
Anshula Gautam is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Cms Clinical Research?
Unlock and access historical data on people associated with Cms Clinical Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Cms Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cms Clinical Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
